Yudao Bio Funding: $40M Raised, Series A (2022)

Yudao Bio funding overview

Yudao Bio is based in Shanghai, China. Yudao Bio has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Yudao Bio runs through 2022; nothing later has been disclosed. Investors on record include Fosun Pharma, Genesis Capital, KUNLUN, Matrix Partners China, Northern Light Venture Capital, SAIC Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Yudao Bio at a glance

Total raised: $40M
Latest round: Series A
Latest round date: March 2022
Headquarters: Shanghai, China
Notable investors: Fosun Pharma, Genesis Capital, KUNLUN, Matrix Partners China, Northern Light Venture Capital, SAIC Capital, Source Code Capital, Yuansheng Capital

Frequently asked about Yudao Bio funding

How much has Yudao Bio raised?: Yudao Bio has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Yudao Bio?: Fosun Pharma, Genesis Capital, KUNLUN, Matrix Partners China, Northern Light Venture Capital, SAIC Capital are named among the investors backing Yudao Bio.
What was the latest Yudao Bio funding round?: The most recent disclosed round is a Series A, announced in March 2022.
Where is Yudao Bio based?: Yudao Bio is based in Shanghai, China.
When did Yudao Bio last raise?: The last disclosed Yudao Bio round closed in March 2022 at Series A.

Yudao Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

Yudao Bio Funding: $40M Raised, Series A (2022)

Yudao Bio funding overview

Yudao Bio at a glance

Frequently asked about Yudao Bio funding

Companies related to Yudao Bio (20)

Browse related funding lists (8)